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Background: Poor adherence has been identified as the main cause of failure to control hypertension. Poor
adherence to antihypertensive treatment is a significant cardiovascular risk factor, which often remains
unrecognized. There are no previous studies that examined adherence with antihypertensive medication or the
characteristics of the non-adherent patients in Bangladesh.
Objective: This paper aims to describe hypertension and factors affecting adherence to treatment among
hypertensive persons in rural Bangladesh.
Design: The study population included 29,960 men and women aged 25 years and older from three rural demo-
graphic surveillance sites of the International Center forDiarrheal DiseaseResearch, Bangladesh (icddr,b):Matlab,
Abhoynagar, andMirsarai.Datawas collectedbya cross-sectional designondiagnostic provider, initial, and current
treatment. Discontinuation of medication at the time of interview was defined as non-adherence to treatment.
Results: The prevalence of hypertension was 13.67%. Qualified providers diagnosed only 53.5% of the
hypertension (MBBS doctors 46.1 and specialized doctors 7.4%). Among the unqualified providers, village
doctors diagnosed 40.7%, and others (nurse, health worker, paramedic, homeopath, spiritual healer, and
pharmacy man) each diagnosed less than 5%. Of those who started treatment upon being diagnosed with
hypertension, 26% discontinued the use of medication. Age, sex, education, wealth, and type of provider were
independently associated with non-adherence to medication. More men discontinued the treatment than
women (odds ratio [OR] 1.74, confidence interval [CI] 1.482.04). Non-adherence was greater when hyperten-
sion was diagnosed by unqualified providers (OR 1.52, CI 1.311.77). Hypertensive patients of older age,
least poor quintile, and higher education were less likely to be non-adherent. Patients with cardiovascular
comorbidity were also less likely to be non-adherent to antihypertensive medication (OR 0.79, CI 0.640.97).
Conclusions: Although village doctors diagnose 40% of hypertension, their treatments are associated with
a higher rate of non-adherence to medication. The hypertension care practices of the village doctors should
be explored by additional research. More emphasis should be placed on men, young people, and people with
low education. Health programs focused on education regarding the importance of taking continuous
antihypertensive medication is now of utmost importance.
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W
orldwide, 13.5% of all premature deaths are at-
tributable to high blood pressure (HBP) (1).
Elevated blood pressure accounts for two-
thirds and one-half of all cases of stroke and ischemic
heart disease, respectively. Eighty percent of this burden
occurred in low- and middle-income countries (2). Treat-
ment reduces the risk of stroke by 3041% and of coro-
nary heart diseases by 22% (3). Despite the availability of
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effective treatments, studies have shown that in many
countries, less than 25% of patients treated for hyperten-
sion achieve optimum blood pressure (4).
Detection, treatment, and control of hypertension are
considered to be inadequate in many high-income coun-
tries; in low-income countries, where awareness about
hypertension is generally low, the situation is even worse
(58). A recent study in the Netherlands showed only a
third of the individuals with hypertension were aware of
their condition and among those aware about 60% were
treated but only 42% had their blood pressure well con-
trolled (9). Another study in China reported only 31% of
the people with hypertension were treated and only 20%
were controlled (10). In the United States, 65% of hyper-
tensive individuals received treatment and nearly 50%were
controlled (11). In Venezuela, only 4.5% of the treated
patients had good blood pressure control (12). Poor
adherence has been identified as the main cause of failure
to control hypertension (4, 13). Poor adherence to anti-
hypertensive treatment is a significant cardiovascular risk
factor, whichmany a times remains unrecognized (4). Poor
adherence to antihypertensive therapy increases the risk of
stroke among the hypertensive individuals (14). The most
important aims for the adequate control of hypertension
are daily compliance and long-term adherence to therapy
(15). Studies found that patients with hypertension tend to
take less than half of their prescribed medications (16).
Previous research has shown that among elderly
hypertensive patients taking medication, only 10% were
well controlled (6). In a recent study among the elderly
people in the Matlab Health and Demographic Surveil-
lance Area, prevalence of hypertension is 50% among the
elderly people of rural Bangladesh (17), but only 26% had
control of their blood pressure (data not published).
Information regarding current management practices for
hypertension is scarce in rural Bangladesh. There is no
existing study to examine adherence with antihyperten-
sive medication and none has examined the character-
istics of the non-adherent patients in Bangladesh. The
aim of the study was to describe hypertension and the
determinants of non-adherence to treatment among adult
hypertensive persons in rural Bangladesh.
Methods
Ethical approval
Ethical approval for surveillance site activities has been
obtained from the International Center for Diarrheal
Disease Research, Bangladesh (icddr,b) review board and
Human Research Ethics Committee, The University of
Newcastle, Australia.
Study sites
The study population was obtained from three rural
demographic surveillance sites, Matlab, Abhoynagar, and
Mirsarai. Table 1 describes the comparative character-
istics of these three sites.
The three rural sites are similar in terms of population
composition, density, household size, primary occupation,
religion, and their disease profile; and also in area
characteristics (1820). Rural Bangladesh is mostly plain
land and riverine area. In general, the public health care
delivery is very homogenous across the country. The
services of community health workers, village doctors,
and so on are very similar across the sites. Furthermore,
there is no specific initiative from any public or private
organizations to date, regarding managing chronic condi-
tions per se hypertension, in these sites. The population
Table 1. Characteristics of the three study sites
Characteristics Matlab Mirsarai Abhoynagar
Rural/urban Rural Rural Rural
Location 55 km southeast of capital city (nearly
central in the country)
Southeastern part of the country Southwestern part of the country
Average household
income
Per capita household income in 2001
approx. 9,000 BDT
8,040 BDT/month
Median 6,000 BDT
5,609 BDT/month
Median 4,000 BDT
Total surveillance
population in 2009
113,186 39,025 34,717
Sample population
Men 1,648 3,584 4,435
Women 4,725 8,410 7,158
Disease profile is
predominantly
Fever, digestive disturbance, and
respiratory disease
Fever, digestive disturbance, and
respiratory disease
Fever, digestive disturbance, and
respiratory disease
Population Density 1,100 persons/km2 1,067 persons/km2 1,067 persons/km2
Household size 5.1 persons 5.4 persons 5.4 persons
Primary occupation Cultivation Cultivation Cultivation
Religion Muslims (90%) Muslims (80%) Muslims (80%)
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under research was from icddr,b surveillance sites where
icddr,b has been maintaining contact with the population
in a very similar fashion across the sites for many years:
in Matlab since the early 1960s, and in Mirsarai and
Abhoynagar since the early 1980s. The sampling design of
the Health and Sociodemographic Surveillance System
(HDSS) was a stratified two-stage sampling; unions were
stratified initially. Unions are administrative subunits in
Bangladesh with a population of approximately 20,000 to
30,000. Each unions were randomly selected. Households
served as the second stage sampling units. A systematic
random sampling technique was applied to select the
sample households.
Among sample households, all household members
were identified and listed to collect basic socioeconomic
and demographic data, and a unique identification num-
ber was assigned to each individual. At regular 90-days
intervals, one female interviewer visited each household
to collect data on demographic and other programmatic
events. HDSS is a cohort study, but this study presents
a cross-sectional analysis of base-line data regarding
hypertension medication adherence in HDSS population.
Study population
The study population was limited to individuals aged
25 years and above. Data was collected in a cross-
sectional survey during the year 2009, for a 2-month
period at each site. The study population was sampled
by door to door survey, during the regular surveillance
rounds. In Abhoynagar and Mirsarai, an attempt was
made to include respondents from all households, and in
Matlab about 6,400 individuals were interviewed, evenly
distributed across the research area.
Because information was collected during regular
household visits, only those present during the visit, and
meeting the age criterion were included. This resulted in a
biased selection of respondents, with an overrepresen-
tation of women. To adjust for this bias, the research
population was weighted to match the relative agesex
distribution of the populations each of the surveillance
sites. In order to give equal weight to the three rural
surveillance sites, the sampled population for Matlab was
inflated to meet the sample size of the other two sites.
Data were collected during the regular visits and only
those present at the time of interview were included. We
did not track the non-response rate as the sample was not
drawn from our defined HDSS surveillance population.
However, a typical estimate of absenteeism of a given
household is approximately less than 5% in the HDSS
surveillance sites (21). In total 29,960 individuals were
included.
Data collection
Trained research assistants conducted the face-to-face
interviews in Bangla using a two-part questionnaire on
chronic disease lifestyle risk factors and management.
The questionnaire was translated to English and then
back translated to Bangla to check the consistency of the
meaning. We then piloted the questionnaire with 10
people from an area similar to but other than the study
sites, to see the understandability of the questionnaire,
language, and so on. This pretested structured question-
naire collected information on 11 prespecified chronic
conditions regarding diagnoses, initial treatment, current
treatment, and health care provider. Respondents were
asked ‘Have you ever been told by any of the following
personnel: MBBS doctor, specialized doctor, nurse,
health worker, paramedic (Medical assistant/sub assistant
community medical office), village doctor/quack, homeo-
path, kabiraj, or pharmacy man that you have any of the
following medical conditions: hypertension, diabetes,
abnormal blood lipids, overweight, chronic bronchitis,
heart attack, angina/coronary heart disease, stroke,
asthma, oral cancer, lung cancer and others’. Respondents
then needed to identify the most recent provider of the
diagnoses. Diagnosis was solely based on self-reporting;
details such as symptoms, signs, or lab tests were not
included. All the information collected in this study was
self-reported. We only reported about the hypertension in
this paper.
Dependent and independent variables
The dependent variable for this study was non-adherence
to antihypertensive treatment, which we have defined as
discontinuation of medication at the time of interview,
when treatment was received at initial diagnosis. It is
categorized in to ‘yes’ and ‘no’. The independent vari-
ables were age, sex, education, asset index, comorbidity,
and health care provider. The individual sociodemo-
graphic factors were derived from preexisting surveillance
data.
Definitions
Hypertension
Hypertension was diagnosed in this study by asking the
respondents: ‘Have you ever been told by any of the
following personnel: MBBS doctor, specialized doctor,
nurse, health worker, paramedic (Medical assistant/sub
assistant community medical office), village doctor/
quack, homeopath, kabiraj, or pharmacy man that you
have hypertension?’ Hypertension diagnosis is not based
on blood pressure measurements; rather we used face-to-
face interviews with a structured questionnaire. For the
validity of the diagnosis we have asked who provided the
diagnosis and to strengthen the diagnostic work we have
also asked if they were taking any medication for their
hypertension diagnosis. Community health workers or in-
formal health providers or unqualified providers, whatever
we want to call, they provide extensive health services in
low-income countries. Unqualified providers are crucial
to Bangladesh’s pluralistic health care system. Ninety-
two percent of the unqualified providers (Bangladesh
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is divided in 64 districts, second tier for administrative
purposes) have district level training and more than 96%
have specific training on hypertension (22).
Asset index
The asset index was assessed based on household assets
and housing characteristics, including bed, mattress,
quilt, cooking pots, watch, chair, clothing cabinet, radio,
television, bicycle, boat, cows, and electricity. Using a
variable reduction technique, these assets and character-
istics were combined into a single variable. Details about
the calculation of the asset index can be found in other
publications from the Matlab HDSS (23). After ranking
this variable from low to high, households were divided
into five equally sized groups, the poverty quintiles. This
procedure was repeated for each site; household stratifi-
cation did not account for possible poverty/wealth
differences between sites.
Comorbidity
Comorbidity was defined when respondents reported
being diagnosed with cardiovascular diseases, other than
hypertension, abnormal blood lipids, or overweight. Diag-
nosing provider was categorized as qualified doctors
(MBBS and specialized physicians) and unqualified pro-
viders (nurses, health workers, paramedics, village doctors,
homeopath, kabiraz/spiritual healers, and pharmacy).
Statistical analyses
Data was presented with mean (standard deviation, SD)
for continuous variables and with proportion for catego-
rical variables. The overall and sex-specific prevalences
of hypertension were calculated. The study participants
were divided into four age groups (B40, 4049, 5059,
and 60 years). Categorical variables were compared by
chi-square statistics.
Univariate regression analysiswas performed to identify
the factors that were associated with non-adherence. Any
factor that provided a univariate p-value B0.05 was
entered into a multiple regression model. Logistic regres-
sion analyses were performed to estimate odds ratios (OR)
and 95% confidence intervals (CI) of non-adherence
associated with various factors, with and without adjust-
ment for other explanatory variables. SAS (Version 8)
Statistical software was used for the analysis.
Results
The study population comprised 52.6% women, mean age
was 44.6 years, with 17% belonging to the age group of 60
years and above. Those who had no formal education
amounted to 43.7%. The prevalence of hypertension was
13.67%, higher for women (14.8%) than men (8.9%)
(pB0.0001). Prevalence of hypertension increased with
age (5.9% in the youngest age group compared to 23.1%
in the oldest age group; pB0.0001), higher among the
least poor quintile compared to the poorest quintile
(20.6% vs. 6.3%, pB0.0001), and higher with increasing
education (no formal education 12.2% vs. highest educa-
tion 16.9%) (pB0.0001) (Table 2).
Only 58% of men and 51.1% of women with hyperten-
sion were diagnosed by qualified doctors. Among the
unqualified providers, village doctors diagnosed 37% of
the men and 42.7% of the women (Table 3).
The proportion of people non-adherent to treatment
was 26.2% in the study population. Non-adherence to
treatment was higher among men (29.2%) than women
(24.3%) (pB0.0001). Non-adherence to treatment de-
creased with age (pB0.0001) (Fig. 1). Non-adherence
was less common among the wealthy people, both for
men and women (Fig. 2).
Age, sex, education, wealth, comorbidity, and type of pro-
viders were independently associatedwith non-adherence to
antihypertensive medication. More men were non-adherent
to the treatment than women (OR 1.67, CI 1.421.97).
Non-adherence to medication was greater when hyper-
tension was diagnosed by unqualified providers (OR 1.46,
CI 1.311.77). People of older age, higher education, and
with most wealth were less likely to be non-adherent.
Those who reported cardiovascular comorbidity (angina,
heart attack, or stroke) were more likely to be compliant
to medication (OR 0.78, CI 0.640.97) (Table 4).
Discussion
This is the first study reporting prevalence and correlates
of non-adherence to antihypertensive treatment in rural
Bangladesh. The prevalence of hypertension is 13.67%
(95% CI 13.2914.07) in this study. A recent study
conducted in the same areas of Bangladesh reported that
the prevalence of hypertension varied from 9.3 to 24.1%
(24). A recent systematic review and meta-analysis of
studies between 1995 and 2010 showed the pooled
prevalence of hypertension in Bangladesh was 13.7%
(overall prevalence estimate ranged between 9 and 22.2%)
(25). Although we have collected self-reported informa-
tion, the prevalence of hypertension reflects the magnitude
of hypertension in rural Bangladesh very well. We have
found that the prevalence of hypertension is significantly
higher for women compared to men, consistent with other
studies in rural Bangladesh. (26). Our finding that the
prevalence is rising with increasing wealth is consistent
with findings from other rural areas in Bangladesh (27).
We have found that more than 26% of the study
population is non-adherent to antihypertensive treatment.
In developed countries, adherence among patients suffer-
ing from non-communicable diseases averages only
50% (28). In China and the Gambia, only 43 and 27% of
patientswith hypertension adhere to their antihypertensive
medication regimen, respectively (29, 30). In developing
countries, the magnitude of poor adherence is assumed to
be higher given the scarcity of health resources and
difficulties in access to health care (31).
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The reasons for poor adherence have been studied
extensively in the West. Two of the most important
factors contributing to poor adherence are the asympto-
matic and lifelong nature of the disease. Other potential
determinants of adherence may be related to demo-
graphic factors such as age and education, the patient’s
understanding and perception of hypertension, the health
care provider’s mode of delivering treatment, and the
relationship between patients and health care profes-
sionals (32, 33). Data from the developing world, in this
regard are scanty, with details of the prevalence of the
condition has just beginning to emerge.
We have found that men in rural Bangladesh are most
likely to discontinue the treatment. Similar findings were
observed in other studies (34); however, opposing find-
ings have also been reported (35). Our study showed that
young hypertensive patients are less likely to continue
antihypertensive treatment, in line with other findings
(3436). As the symptoms go unnoticed, young indivi-
duals may not pay much attention to the importance
of continuing medication. This needs more exploration
as an area of intervention. Sex and age are affecting
adherence to treatment as in other diseases too (37).
Poor socioeconomic status and low education are
important factors for poor adherence (3840); our find-
ings are in line with these evidences. Although the
exact cause could not be revealed in this study, people
with higher education and more wealth may be more
health conscious and knowledgeable about the impact of
poor control of HBP. Studies found that non-adherent
patients with lower income and less education suffered
more from stroke (14). Financial constraints could be a
factor in continuing lifelong medication for hypertension
treatment (32).
Table 2. Characteristics of the study population (n29,960) by hypertension status
Hypertension
Characteristics No. of participants Present Absent p
(n) 29,960 4,097 25,863
Age groups, years (%)
B40 43.1 5.9 94.1
4049 23.9 11.8 88.2 B0.001
5059 16.0 17.3 82.7
60 and above 17.0 23.1 76.9
Mean age (std) 44.6 (15.8) 52.8 (14.3) 43.6 (14.1) B0.001
Sex (%)
Male 47.4 8.9 91.1 B0.001
Female 52.6 14.8 85.2
Level of education (%)
No education 43.7 12.1 87.9
Primary (15 years) 26.9 12.0 88.0
Secondary (610 years) 24.5 11.9 88.1 0.727
Higher (11 years) 4.8 12.8 87.2
Years of education (std) 3.6 (4.4) 3.7 (4.0) 3.6 (4.0) 0.201
Asset Index (%)
Poorest 20% 16.3 6.5 93.5
Poorer 20% 18.2 9.0 91.0
Middle 20% 20.0 10.5 89.5
Less poor 20% 22.0 13.4 76.6 B0.001
Least poor 20% 23.6 18.9 81.1
Table 3. Hypertension diagnosed by type of health care
providers and sex in rural Bangladesh
Diagnosis of hypertension (%)
Male Female Total p
MBBS doctor 48.8 44.5 46.1 0.007
Specialized doctor 9.1 6.5 7.4 0.002
Nurse 0.0 0.1 0.1 0.168
Health worker 0.3 0.3 0.3 0.858
Paramedic 3.3 4.5 4.1 0.054
Quack/village doctor 37.0 42.7 40.7 0.001
Homeopath 0.6 0.6 0.6 0.931
Kabiraz/spiritual healer 0.1 0.0 0.0 0.418
Pharmacy 0.7 0.7 0.7 0.869
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We have found that in the presence of cardiovascular
comorbidities (vascular diseases, abnormal lipids, and
overweight) the odds of non-adherence to antihypertensive
medication are reduced. The reason could be numerous;
patients with comorbidities visit health care providers
more frequently, they pay more attention to their health
conditions, and also are more likely to go to a qualified
health care provider and therefore more likely to continue
medication in general. Specific reasons for this population
are yet to be revealed as aspects of multimorbidity and
polypharmacy are underresearched in Bangladesh.
In this study, non-adherence is more when hyperten-
sion was diagnosed by village doctors. The influence of
factors related to the health care provider on adherence
to therapy for hypertension has not been systematically
studied. One important factor is probably lack of knowl-
edge and training for health care providers on managing
hypertension per se chronic diseases (41, 42). These
factors may contribute to the fact of more than 40% of
people being diagnosed as hypertensive by the village
doctors.
We have mainly focused on demographic and economic
factors such as age, sex, education, and wealth, some of
which are results of social determinants, that influence
adherence to treatment. This study has highlighted the
importance of health care providers in patient adherence
to antihypertensive therapy, and the extent of poor adher-
ence, especially when unqualified providers, for example,
village doctors, play a prominent role in diagnosing the
condition. We have used the education and asset index
data, as in many earlier reports, to shed some light on
the financial aspects of this study outcome, as there is a
positive correlation between educational level and income.
Unfortunately, we do not have any data about the cost
borne by the patients of this study; neither do we have
any data regarding usual cost of antihypertensive drugs.
However, a publication on availability and affordability
of essential medicines for chronic diseases in low-income
countries mentioned that median price ratio is between
1.14 and 1.31 in Bangladesh (this ratio compares a
medicine’s median price to its international reference
price) (43).
Fig. 2. Percentage of people non-adherent to treatment by sex and asset quintile.
*Absolute numbers of samples are shown in the parenthesis.
Fig. 1. Percentage of people non-adherent to treatment by age group and sex, in rural Bangladesh, 2009.
*Absolute numbers of samples are shown in the parenthesis.
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Several limitations should be mentioned. We have used
the self-reported information because this is easy, econom-
ical, and has long been used as an epidemiological tool.
This may be subject to recall bias and possibility of
underestimation of actual prevalence. We have a robust
phenomenon in place, our surveillance system. The
surveillance people are in acquaintance with routine
questionnaires and interviewers, decreasing the likelihood
of reporting bias. In checking for the validity of hyperten-
sion diagnosis, participants were not only asked about the
providers of the diagnosis but also asked about taking
antihypertensive medication. However the focus of this
paper was mainly the adherence to treatment for the
hypertensive patients. There are more validated measures
of medication adherence, where objective measures are
used to specify the adherence. This is the first of its kind
study on adherence to antihypertensive treatments in
Bangladesh, and conducted on surveillance population.
Among the several strengths, this study covers a wide
geographical area, provides initial steps of nationally
representative data, and includes large sample size that
supports the accuracy of our findings. HDSS collect
information from whole communities over extended time
periods, which more accurately reflect health and popu-
lation problems in low- and middle-income countries.
HDSS provides a reliable sampling frame and a high
response rate is usually observed.
Conclusions
Although village doctors make 40% of hypertension
diagnoses, their treatments are associated with a higher
rate of discontinuation. The hypertension management
practices of the village doctors should be explored in
subsequent research. More research is needed for better
understanding of the determinants of adherence, also to
find out the reasons for non-adherence to treatment
particularly among men and young people. Accordingly,
effective interventions need to be developed to properly
manage hypertension and chronic diseases in general.
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